PATENT CLAIM ANALYSIS

Application Number: 16120170
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["544", "324000"]

Abstract:
A compound of formula (I), or a pharmaceutically acceptable salt thereof, for use in the treatment of autoimmune diseases and inflammatory conditions.

Claim (Index 48):
The method as claimed in  claim 32 , wherein R 3  represents \u2014C 1-6 alkyl optionally substituted by one or more groups selected from Z 1 .

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.08
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15447818', '14647400', '15899061', '15315461', '15315478']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8185321458971179
- 35 USC 102 Novelty (BERT): 0.5834362498910434
- Combined Prediction Score: 0.7950225562965105
- Mean Citation Score: 477.80761600000005
- Max Citation Score: 496.26343
- Similarity Product: 417.7902452740556

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test